P1.43 Framingham Score Underdiagnoses Vascular Disease in Patients Under Cardiovascular Prevention
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
P1.43 Framingham Score Underdiagnoses Vascular Disease in Patients Under Cardiovascular Prevention ; volume:2 ; number:3 ; day:15 ; month:9 ; year:2008 ; pages:102 ; date:8.2008
Artery research ; 2, Heft 3 (15.9.2008), 102, 8.2008
- Creator
-
Forcada, P.
Kotliar, C.
Obregon, S.
Montana, O.
Schulte, C.
Millet, G.
Guerrieri, J.
Turri, D.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1016/j.artres.2008.08.350
- URN
-
urn:nbn:de:101:1-2405021316137.392483675462
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Forcada, P.
- Kotliar, C.
- Obregon, S.
- Montana, O.
- Schulte, C.
- Millet, G.
- Guerrieri, J.
- Turri, D.
- SpringerLink (Online service)
Other Objects (12)
The risk of cardiovascular disease following breast cancer by Framingham risk score
Comparison of Framingham, PROCAM, SCORE, and Diamond Forrester to predict coronary atherosclerosis and cardiovascular events
Sleep duration and Framingham´s cardiovascular risk score: results from the Hoveyzeh Cohort Study (HCS)
Association between health literacy and Framingham risk score
Framingham risk score for estimation of 10-years of cardiovascular diseases risk in patients with metabolic syndrome
P6.11 The Framingham Risk Score in Chronic Obstructive Pulmonary Disease
P4.7 Relationship of Different Cardiovascular Tissue Biomarkers with Established Risk Factors and Framingham Risk Score in Middle-Age Subjects without Cardiovascular Events
Comparison Between Metabolic Syndrome and the Framingham Risk Score as Predictors of Cardiovascular Diseases Among Kazakhs in Xinjiang
Impact of modifiable risk factors on prediction of 10-year cardiovascular disease utilizing framingham risk score in Southwest Iran
Independent external validation of cardiovascular disease mortality in women utilising Framingham and SCORE risk models: a mortality follow-up study
Statistical evaluation of adding multiple risk factors improves Framingham stroke risk score
The Framingham risk score is associated with incident frailty, or is it?
The risk of cardiovascular disease following breast cancer by Framingham risk score
Comparison of Framingham, PROCAM, SCORE, and Diamond Forrester to predict coronary atherosclerosis and cardiovascular events
Sleep duration and Framingham´s cardiovascular risk score: results from the Hoveyzeh Cohort Study (HCS)
Association between health literacy and Framingham risk score
Framingham risk score for estimation of 10-years of cardiovascular diseases risk in patients with metabolic syndrome
P6.11 The Framingham Risk Score in Chronic Obstructive Pulmonary Disease
P4.7 Relationship of Different Cardiovascular Tissue Biomarkers with Established Risk Factors and Framingham Risk Score in Middle-Age Subjects without Cardiovascular Events
Comparison Between Metabolic Syndrome and the Framingham Risk Score as Predictors of Cardiovascular Diseases Among Kazakhs in Xinjiang
Impact of modifiable risk factors on prediction of 10-year cardiovascular disease utilizing framingham risk score in Southwest Iran
Independent external validation of cardiovascular disease mortality in women utilising Framingham and SCORE risk models: a mortality follow-up study
Statistical evaluation of adding multiple risk factors improves Framingham stroke risk score
The Framingham risk score is associated with incident frailty, or is it?
The risk of cardiovascular disease following breast cancer by Framingham risk score
Comparison of Framingham, PROCAM, SCORE, and Diamond Forrester to predict coronary atherosclerosis and cardiovascular events
Sleep duration and Framingham´s cardiovascular risk score: results from the Hoveyzeh Cohort Study (HCS)
Association between health literacy and Framingham risk score
Framingham risk score for estimation of 10-years of cardiovascular diseases risk in patients with metabolic syndrome
P6.11 The Framingham Risk Score in Chronic Obstructive Pulmonary Disease
P4.7 Relationship of Different Cardiovascular Tissue Biomarkers with Established Risk Factors and Framingham Risk Score in Middle-Age Subjects without Cardiovascular Events
Comparison Between Metabolic Syndrome and the Framingham Risk Score as Predictors of Cardiovascular Diseases Among Kazakhs in Xinjiang
Impact of modifiable risk factors on prediction of 10-year cardiovascular disease utilizing framingham risk score in Southwest Iran
Independent external validation of cardiovascular disease mortality in women utilising Framingham and SCORE risk models: a mortality follow-up study
Statistical evaluation of adding multiple risk factors improves Framingham stroke risk score